1. Anti-infection
  2. Bacterial Penicillin-binding protein (PBP)
  3. VNRX-14079

VNRX-14079 是一种抗菌剂 (Antibacterial) 和 PBP2 抑制剂,对野生型淋病奈瑟菌 PBP2 的 IC50 值为 1.7 μM。VNRX-14079 可与 PBP2 的 Ser310 形成共价键,与 PBP2 的多个残基相互作用,稳定复合物,并在嵌合型 PBP2 中诱导 β34 环向内的构象。VNRX-14079 对耐 Ceftriaxone (HY-B0712) 的淋病奈瑟菌菌株具有抗菌活性。VNRX-14079 可用于淋病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

VNRX-14079

VNRX-14079 Chemical Structure

CAS No. : 2872654-37-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

VNRX-14079 is an antibacterial agent and PBP2 inhibitor, with an IC50 value of 1.7 μM against wild-type Neisseria gonorrhoeae PBP2. VNRX-14079 forms a covalent bond with Ser310 of PBP2, interacts with multiple residues of PBP2 to stabilize the complex, and induces an inward conformational change of the β34 loop in chimeric PBP2. VNRX-14079 exhibits antibacterial activity against Ceftriaxone (HY-B0712)-resistant Neisseria gonorrhoeae strains. VNRX-14079 can be used in the research of gonorrhea[1].

体外研究
(In Vitro)

VNRX-14079 结合野生型淋病奈瑟菌 (FA19 菌株) 的 PBP2,其 IC50 为 1.7 µM[1]
VNRX-14079 可结合来自 H041 菌株的嵌合淋病奈瑟菌 PBP2,其 IC50 为 3.0 µM[1]
VNRX-14079 (24 h) 对大多数产生非嵌合型和嵌合型 PBP2 的淋病奈瑟菌菌株表现出强效抗菌活性[1]
VNRX-14079 (4× MIC-16× MIC; 2-24 h) 对淋病奈瑟菌 ATCC 49226、WHO Q 和 H041 表现出快速杀菌活性,在 4× 和 16× MIC 条件下,6 小时内可使细菌数量减少 ≥2 log10,24 小时内降至检测不到的水平[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

VNRX-14079 (10-200 mg/kg;皮下注射;每 8 小时至每 24 小时给 1 次) 在小鼠阴道感染模型中对头孢曲松耐受的淋病奈瑟菌 (N. gonorrhoeae) H041 表现出强大的体内抗菌作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NCI BALB/c (female, 6-7 weeks old, pretreated with 17β oestradiol and antibiotics to suppress commensal microbiota, vaginally infected with ceftriaxone-resistant Neisseria gonorrhoeae H041)[1]
Dosage: 10 mg/kg; 200 mg/kg; 150 mg/kg
Administration: s.c.; q12h (total 2 doses on day 1); q24h (single dose on day 1); q8h (total 3 doses on day 1)
Result: Achieved 80% bacterial clearance by day 4 with statistically significant reduction in culture-positive mice relative to vehicle controls (P < 0.01) at 10 mg/kg q12h.
Achieved 100% clearance by day 3 with predicted 44% free unbound drug concentration above the MIC over 24 hours at 200 mg/kg q24h.
Resulted in 90% clearance by day 2 at 150 mg/kg q12h.
Achieved 100% clearance by day 2 at 150 mg/kg q8h.
Showed reduced average bacterial burden consistent with clearance rates across all doses.
Detected no evolution of spontaneous gonococcal mutants or adverse effects across all doses.
分子量

646.28

Formula

C22H22BF2N4O12PS

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
VNRX-14079
目录号:
HY-183080
需求量: